Engie Q1 EBITDA Rises; Backs FY Net Recurring Income Outlook

French natural gas and electricity supplier Engie SA (ENGQF.PK,ENGIY.PK) reported that its first-quarter EBITDA was 3.2 billion euros, up 5% on a gross basis and up 7% on an organic basis.

EBIT was 2.1 billion euros, up 8% on a gross basis and up 10% on an organic basis.

Revenues were 16.9 billion euros, up 2% on a gross basis and up 5% on an organic basis. Impact from foreign exchange was mainly from the depreciation of the US dollar and Brazilian real against the euro. On an organic basis, revenues increased primarily due to colder temperature, increase in commodity prices, recovery on Client Solutions activities and renewables assets commissioned last year.

For the full year 2021, Engie reaffirmed its net recurring income group share guidance in a range of 2.3 billion euros - 2.5 billion euros. The guidance is based on an indicative EBITDA range of 9.9 billion euros to 10.3 billion euros and EBIT range of 5.2 billion euros to 5.6 billion euros.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Covid vaccine makers Pfizer Inc. and BioNTech SE announced a new $3.2 billion vaccine supply deal with the U.S. Government, as the country is bracing for a Covid outbreak this fall. Under the deal, the U.S. government will receive 105 million doses (30 µg, 10 µg and 3 µg) of Pfizer -BioNTech covid vaccines initially. The order may include adult Omicron-adapted COVID-19 vaccines. Samsung Electronics Co. has started the initial mass production of 3-nanometer or nm chips, which is considered as the most advanced chip in the world. In its move, the South Korean tech major beats rival Taiwan Semiconductor Manufacturing Co., the world's largest chip manufacturer, which is reportedly in the process to build one. Bryant Ranch Prepack Inc. is recalling certain Morphine Sulfate Extended-Release Tablets citing incorrect labeling, the U.S. Food and Drug Administration said. The recall involves one lot of Morphine Sulfate 30 mg Extended-Release tablets, and one lot of Morphine Sulfate 60 mg Extended-Release tablets to the consumer level.
Follow RTT